Why might Enterobacteriaceae be seen as a major public health concern?

Why might Enterobacteriaceae be seen as a major public health concern?

• A. They often exhibit antibiotic sensitivity
• B. They are non-pathogenic
• C. They often exhibit multi-drug resistance
• D. They are easily eliminated with vaccines

Answer: (C)

Enterobacteriaceae is a significant public health concern primarily due to their tendency to exhibit multi-drug resistance. This family of bacteria includes pathogens such as Escherichia coli and Klebsiella pneumoniae, which can cause a variety of infections, including urinary tract infections, bloodstream infections, and pneumonia. The emergence of strains that are resistant to multiple classes of antibiotics complicates treatment options and poses a serious challenge to healthcare systems. The multi-drug resistant nature of these bacteria can result from several factors, including the overuse and misuse of antibiotics, which promote the selection of resistant strains. As a result, infections caused by these bacteria can lead to increased morbidity, prolonged hospital stays, and higher healthcare costs. In some cases, treatment options become severely limited, leading to worse outcomes for patients. The other options do not accurately represent the public health implications associated with Enterobacteriaceae. For instance, while sensitivity to antibiotics is a crucial aspect of treatment strategies, the reality is that many strains are resistant. Non-pathogenic strains do exist within this family, but the focus on public health typically revolves around those that cause disease. Lastly, the development and availability of effective vaccines against Enterobacteriaceae are limited, further underscoring the significance of

Enterobacteriaceae is a significant public health concern primarily due to their tendency to exhibit multi-drug resistance. This family of bacteria includes pathogens such as Escherichia coli and Klebsiella pneumoniae, which can cause a variety of infections, including urinary tract infections, bloodstream infections, and pneumonia. The emergence of strains that are resistant to multiple classes of antibiotics complicates treatment options and poses a serious challenge to healthcare systems.

The multi-drug resistant nature of these bacteria can result from several factors, including the overuse and misuse of antibiotics, which promote the selection of resistant strains. As a result, infections caused by these bacteria can lead to increased morbidity, prolonged hospital stays, and higher healthcare costs. In some cases, treatment options become severely limited, leading to worse outcomes for patients.

The other options do not accurately represent the public health implications associated with Enterobacteriaceae. For instance, while sensitivity to antibiotics is a crucial aspect of treatment strategies, the reality is that many strains are resistant. Non-pathogenic strains do exist within this family, but the focus on public health typically revolves around those that cause disease. Lastly, the development and availability of effective vaccines against Enterobacteriaceae are limited, further underscoring the significance of